# Ritodrine

## Anpo inj 50mg/5mL

##### 

| TAH Drug Code      | [IANP](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IANP)                                                                                                                                                                                                                                                                                                                           |
|:-------------------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Prevention of preterm labour, Acute fetal distress, Prevention of preterm labour after operation.                                                                                                                                                                                                                                                                                              |
| Dosing             | Uncomplicated premature labour: IV infusion, initially 0.05 mg/min. Increase by 0.05 mg/minute every 10 min until patient responds. Usual rate: 0.15-0.35 mg/minute. Maintain for 12-48 hour after the contractions have stopped. As IM injection: initially 10 mg for 1 hour. then 10-20mg every 2-6 hours maintain for 12-48 hours. Increase or decrease the dose depending on the response. |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                  |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                  |
| Contraindications  | Antepartum haemorrhage due to any cause but particularly placenta previa & abruptio placentae. Eclampsia & severe pre-eclampsia. Intra-uterine foetal death. Chorioamnionitis. Maternal cardiac disorder. Hyperthyroidism. Uncontrolled hypertension. Any other condition which can endanger cardiac function. Parenteral: Asthmatics (due to sulfite component).                              |
| Adverse Effects    | Pulmonary oedema (several cases reported with fatal results). Maternal & foetal heart rate can increase. Frequently: Tremor, nausea, vomiting, headache or erythema, nervousness, restlessness, jitteriness, emotional upset, anxiety or malaise. Infrequently cardiac symptoms, eg chest pain or tightness with or without ECG abnormalities & cardiac arrhythmias. Hepatic impairment.       |
| Pregnancy          | Unknown                                                                                                                                                                                                                                                                                                                                                                                        |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                  |

## Anpo 10mg

##### 

| TAH Drug Code      | [OANP](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OANP)                                                                                                                                                                                                                                                                                                                     |
|:-------------------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Prevention of preterm labour, Acute fetal distress, Prevention of preterm labour after operation Follow treatment for preterm labour.                                                                                                                                                                                                                                                    |
| Dosing             | Uncomplicated premature labour Adult: Start oral therapy 30 minutes before termination of IV infusion at 10 mg every 2 hours for 24 hours. Subsequently, 10-20 mg every 4-6 hours according to patient's response. the maximum oral dose: 120 mg/day.                                                                                                                                    |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                            |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                            |
| Contraindications  | Antepartum haemorrhage due to any cause but particularly placenta previa & abruptio placentae. Eclampsia & severe pre-eclampsia. Intra-uterine foetal death. Chorioamnionitis. Maternal cardiac disorder. Hyperthyroidism. Uncontrolled hypertension. Any other condition which can endanger cardiac function. Parenteral: Asthmatics (due to sulfite component).                        |
| Adverse Effects    | Pulmonary oedema (several cases reported with fatal results). Maternal & foetal heart rate can increase. Frequently: Tremor, nausea, vomiting, headache or erythema, nervousness, restlessness, jitteriness, emotional upset, anxiety or malaise. Infrequently cardiac symptoms, eg chest pain or tightness with or without ECG abnormalities & cardiac arrhythmias. Hepatic impairment. |
| Pregnancy          | Unknown                                                                                                                                                                                                                                                                                                                                                                                  |
| Lactation          | Unknown                                                                                                                                                                                                                                                                                                                                                                                  |

